Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant in children and adolescents with narcolepsy
2013-001506-29Phase 2Completed
- Sponsor
- Bioprojet
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pitolisant in narcolepsy (3 arms), sponsored by Bioprojet. Primary endpoint: Change in excessive daytime sleepiness measured by the Paediatric Daytime Sleepiness Scale. Started Jan 2016; status: completed.
02
Drugs
pitolisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on 2013-001506-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001506-29.